URGN
UroGen PharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
URGN Profile
Urogen Pharma Ltd.
A biotech company that develops novel therapies for urothelial cancer treatment only in a water-based formulation
400 Alexander Park, Princeton, NJ, 08540
--
Urogen Pharma Ltd. was established under the laws of the State of Israel in April 2004 as TheraCoat Ltd. In September 2015, the company changed its name to Urogen Pharma Ltd.. The company is a clinical-stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care in urological pathology.
